期刊文献+

镧-滂胺天蓝光度法测定人血清及尿样中的几种抗生素 被引量:1

Spectrophotometric Determination of Several Antibiotics in Human Serum and Urine Liquid by Lanthanum Ⅲ-Pontamine Sky Blue-Antibiotics System
下载PDF
导出
摘要 在pH 2 .8~ 6 .5的条件下 ,镧 和 6 ,6′ (2 ,2′ -二甲氧基 4 ,4′ -亚联苯基双偶氮 )二 (5 羟基 4 氨基 1 ,3 萘二磺酸钠 ) (滂胺开蒸 ,PSB)与硫酸新霉素 (NEO)、硫酸庆大霉素 (GEN)、硫酸卡那霉素 (KANA)反应生成具有明显显色峰和褪色峰的三元蓝色离子缔合物。其最大显色波长位于 6 88nm ,线性范围从 0~ 1 2 .0mg/L至 0~ 1 4 .0mg/L ,摩尔吸收光系数 (ε)在 3.0 8× 1 0 4~ 4 .6 4× 1 0 4L·mol-1 ·cm-1 之间 ;最大褪色波长在6 1 8~ 6 2 4nm之间 ,线性范围从 0~ 1 2 .0mg/L至 0~ 1 5 .0mg/L ,摩尔吸光系数 (ε)在 4 .4 3× 1 0 4~ 1 .1 3× 1 0 5L·mol-1 ·cm-1 之间。探讨了适宜的反应条件、主要分析化学性质及三元缔合物的络合比。该法用于人血清及尿样中新霉素、卡那霉素及庆大霉素含量的测定 。 In the medium of pH 2.8~6.0, La*# and 6,6′ (2,2′ dimethoxy 4,4′ bisphenlene bisazo)di (5 hydroxy 4 amino 1,3 naphthyl disulfonate) (pontamine sky blue, PSB) reaction with neomycin sulfate(NEO), gentamycin sulfate(GEN) and kanamycin sulfate(KANA), can produce to form three ingredient blue ion association complexes with an obvious absorption peak and an fading peak. The maximum absorption wavelength is 688 nm, and the linear ranges are from 0~12.0 mg/L to 0~14.0 mg/L, and their molar absorptivities ( ε ) are between 3.08×10 4 and 4.64×10 4L·mol -1 ·cm -1 . The maximum fading wavelength is located between 618 nm and 624 nm, and the linear ranges are between 0~12.0 mg/L and 0~15.0 mg/L, and their molar absorptivities ( ε ) are from 4.43×10 4 to 1.13×10 5L·mol -1 ·cm -1 . The optimum reaction conditions and the chief properties of analytical chemistry and the component ratio of three ingredient ion association complexes were studied. The method has been applied to determine the content of neomycin , gentamycin and kanamycin in human serum and urine liquid with satisfactory results.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2004年第8期1043-1046,共4页 Chinese Journal of Analytical Chemistry
基金 重庆市科委基金资助项目 (No .2 0 0 3 8113 )
关键词 人血清 尿液 抗生素 滂胺天蓝 光度法 含量测定 LanthanumⅢ, 6,6′ (2,2′ dimethoxy 4,4′ bisphenlene bisazo)di (5 hydroxy 4 amino 1,3 naphthyl disulfonate), antibiotics, spectrophotometry
  • 相关文献

参考文献9

  • 1Stead D A,Richards R.M.E. J.Chromatogr. B: Biomed. Sci. Appl., 1997, 693: 415-421
  • 2Al-Ghabsha T S. Microchem. J. 1987, 36: 323-328
  • 3Zakhari N A. Anal. Lett., 1990, 23(10): 1843-1856
  • 4Yao Cheng(姚成), Xu Lina(徐丽娜), Wang Zhenpu(王镇浦), Yang Deren(杨德仁). Analytical Laboratory(分析试验室), 1999, 18(1): 16-18
  • 5Hiroak K, Yuesheng H, Toshio K. Bunseki Kagaku, 1989, 38(5): 215
  • 6Rizk M, EL-Shabrawy Y, Zakhari N A, Toubar S S, Carreira L A. Talanta, 1995, 42(12): 1849-1856
  • 7Li Haozhi(李好枝), Gao Guangen(高光恩). Pharmic Journal of Northwest(西北药学杂志), 1995, 10(1): 5
  • 8ThePharmacopoeiaCommitteeofthePeople′sRepulicofChina(中华人民共和国药典委员会编).The Pharmacopoeia of the People′s Repulic of China, 2nd Version[S](中华人民共和国药典(二部[S]))[M].Beijing(北京): Chemical Industr,..
  • 9XiYingxin(郗英欣) LangHuiyun(郎惠云) XieZhihai(谢志海) ZhangQidong(张启东).Journal of Xi′an Jiaotong University(西安交通大学学报),1996,30:104-104.

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部